Symbol="VTYX"
AssetType="Common Stock"
Name="Ventyx Biosciences Inc"
Description="Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company is headquartered in Encinitas, California."
CIK="1851194"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="662 ENCINITAS BLVD., STE. 250, ENCINITAS, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="2177735000"
EBITDA="-132808000"
PERatio="None"
PEGRatio="None"
BookValue="6.37"
DividendPerShare="0"
DividendYield="0"
EPS="-2.26"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.249"
ReturnOnEquityTTM="-0.395"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.26"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="57.58"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="5.01"
EVToRevenue="-"
EVToEBITDA="-16.69"
Beta="None"
num_52WeekHigh="47.25"
num_52WeekLow="15.09"
num_50DayMovingAverage="34.86"
num_200DayMovingAverage="34.54"
SharesOutstanding="58557000"
DividendDate="None"
ExDividendDate="None"
symbol="VTYX"
open="36.58"
high="36.76"
low="35.42"
price="36.68"
volume="323361.00"
latest_trading_day="2023-08-02"
previous_close="37.19"
change="-0.51"
change_percent="-1.3713%"
aroon_positive_momentum_days="49"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="49"
Volume_recent_avg="810452"
Change_recent_avg="-0.02"
Delta_recent_avg="1.87"
Variance_recent_avg="0.93"
Change_ratio_recent_avg="-0.13"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="49"
Aroon_momentum_negative="51"
image_negative_thumbnail_id_1="495"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0110.jpeg"
image_negative_thumbnail_id_2="1143"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0176.jpeg"
image_neutral_thumbnail_id_1="563"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0036.jpeg"
image_neutral_thumbnail_id_2="535"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0064.jpeg"
image_positive_thumbnail_id_1="599"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0109.jpeg"
image_positive_thumbnail_id_2="949"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0111.jpeg"
image_professor_thumbnail_id_1="1191"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
image_professor_thumbnail_id_2="1192"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
